CXCR4-PI3KⅢ-自噬轴与结肠癌LoVo细胞转移潜能相关性研究

来源 :中华肿瘤防治杂志 | 被引量 : 0次 | 上传用户:Jason51090
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:探讨调控CXCR4-PI3KⅢ-自噬轴对结直肠癌LoVo细胞迁移和侵袭能力的影响。方法:实验分为正常LoVo细胞组、介导CXCR4-RNAi慢病毒转染LoVo细胞组(CXCR4-RNAi组)和无意义慢病毒转染LoVo细胞组(NC组)。采用Q-PCR检测PI3KⅢmRNA表达,蛋白质印迹法检测PI3KⅢ、LC3-Ⅱ及Beclin 1的表达,激光共聚焦显微镜观察绿色荧光颗粒,透射电镜观察自噬溶酶体,Transwell小室评价LoVo细胞迁移与侵袭能力。结果:PI3KⅢmRNA表达量正常LoVo细胞组为1.09±0.11,NC组为1.07±0.25,CXCR4-RNAi组为0.86±0.06。PI3KⅢ相对表达量CXCR4-RNAi组为0.227±0.023,低于正常LoVo细胞组的0.607±0.012(P<0.001)和NC组的0.667±0.040(P<0.001),正常LoVo细胞组和NC组差异无统计学意义,P=0.310。LC3-Ⅱ相对表达量CXCR4-RNAi组为0.083±0.012,低于正常LoVo细胞组的0.233±0.015(P<0.001)和NC组的0.253±0.020(P<0.001),正常LoVo细胞组和NC组差异无统计学意义,P=0.184。Beclin 1相对表达量CXCR4-RNAi组为0.207±0.012,低于正常LoVo细胞组的0.440±0.053(P=0.134)和NC组的0.650±0.252,P=0.011。绿色荧光颗粒和自噬溶酶体数量正常LoVo细胞组和NC组明显多于CXCR4-RNAi组。CXCR4-RNAi组迁移实验细胞计数(87.7±9.1)低于正常LoVo细胞组的126.3±4.9(P=0.009)和NC组的115.0±18.7(P=0.035)。CXCR4-RNAi组侵袭实验细胞计数(88.7±10.5)低于正常LoVo细胞组的109.7±4.7(P=0.019)和NC组的107.7±8.1,P=0.029。结论:CXCR4-PI3KⅢ-自噬轴可调控结肠癌LoVo细胞自噬状态,影响肿瘤细胞迁移和浸润,可能是恶性肿瘤浸润转移的机制之一。 Objective: To investigate the effects of CXCR4-PI3KⅢ-autophagic axis on the migration and invasion of colorectal cancer LoVo cells. Methods: The experiment was divided into normal LoVo cell group, CXCR4-RNAi lentivirus transfected LoVo cell group (CXCR4-RNAi group) and nonsense lentivirus transfected LoVo cell group (NC group). The expression of PI3KⅢmRNA was detected by Q-PCR, the expression of PI3KⅢ, LC3-Ⅱ and Beclin 1 were detected by Western blotting. The green fluorescent particles were observed by laser confocal microscopy, the autophagy lysosome was observed by transmission electron microscopy, and the migration and invasion ability of LoVo cells were evaluated by Transwell chamber . Results: The expression level of PI3KⅢmRNA was 1.09 ± 0.11 in LoVo cell group, 1.07 ± 0.25 in NC group and 0.86 ± 0.06 in CXCR4-RNAi group. The relative expression level of PI3KⅢ in CXCR4-RNAi group was 0.227 ± 0.023, lower than that in normal LoVo cells group (0.607 ± 0.012) and 0.667 ± 0.040 (P <0.001) in NC group Statistical significance, P = 0.310. The relative expression level of LC3-Ⅱ in CXCR4-RNAi group was 0.083 ± 0.012, which was lower than that in normal LoVo cell group (0.233 ± 0.015, P <0.001) and NC group (0.253 ± 0.020, P <0.001) The difference was not statistically significant, P = 0.184. Beclin 1 relative expression level was 0.207 ± 0.012 in CXCR4-RNAi group, which was lower than 0.440 ± 0.053 (P = 0.134) in normal LoVo cell group and 0.650 ± 0.252 in NC group (P = 0.011). The number of green fluorescent particles and the number of autophagy lysosomes was significantly higher in LoVo cell group and NC group than in CXCR4-RNAi group. CXCR4-RNAi group migration assay The cell count (87.7 ± 9.1) was lower than that of the normal LoVo cell group by 126.3 ± 4.9 (P = 0.009) and NC group by 115.0 ± 18.7 (P = 0.035). The cell count of invasion assay in CXCR4-RNAi group (88.7 ± 10.5) was lower than 109.7 ± 4.7 (P = 0.019) in normal LoVo cell group and 107.7 ± 8.1 in NC group (P = 0.029). Conclusion: The CXCR4-PI3KⅢ-autophagic axis can regulate the autophagy status of colon cancer LoVo cells and affect tumor cell migration and invasion, which may be one of the mechanisms of invasion and metastasis of malignant tumor.
其他文献
期刊
目的 分析徒手旋转在头位难产产妇助产护理中应用效果.方法 选取40例头位难产产妇,随机分为对照组(20)与观察组(20),对照组根据常规产程采取自然分娩与助产护理,观察组采取徒
目的 对风险管理在骨折临床护理中的应用效果进行探讨.方法 选取2014年1月~2015年4月于我院就诊的患者共110例,将患者按照入院编号随机分为观察组和对照组两组,两组患者各55例
文章在分析了集团公司电网运行管理存在的问题后,结合目前RTU应用情况,提出了以变电站已有的RTU为基础平台,利用其采集的电量参数等资源信息和功能,通过扩充和完善一些必要的
研究了几种常见氨基酸的热稳定性及热降解,建立动力学方程.用TG-DTG热重仪测定氨基酸的热解曲线,用多升温速率法、Coats-Redfern法和Achar微分法确定热分解函数,根据TG-DTG热
会议
目的 研究全麻术后患者麻醉恢复期并发症情况及护理措施.方法 2014年1月~2015年1月我院麻醉恢复室共收活1000例全麻术后患者,选取其中680例患者作为本次研究对象,针对患者并发
目的 分析对妇产科习惯性流产患者进行综合护理的疗效.方法 抽选本医院妇产科习惯性流产患者70例,分成护理组和对照组.对照组接受普通看护,护理组接受综合护理,比较不同护理
目的 探讨电视胸腔镜食管癌切除术式在食管癌治疗上的技术可行性和临床效果.方法 回顾分析2011年2月~2015年1月我科收治的82例食管癌患者的临床资料,电视胸腔镜手术组26例,常
本文论述了MQAM的原理以及在HFC调制解调器中的应用,由于HFC的网络结构简单,在加上相应的设备就可实现双向数据通信,适合现阶段使用.
目的 探讨在慢性阻塞性肺病合并Ⅱ型呼吸衰竭患者临床护理中无创正压通气的应用效果,为其临床有效护理提供重要依据.方法 选取2013年12月~2014年12月我院收治的慢性阻塞性肺病